Tag: Trial
Eyestem completes Phase 1 of its RPE Cell Therapy with promising...
Phase 2 of the trial will begin as soon as Eyestem receives approval from the CDSCO
MedTech Breakthrough: SS Innovations achieves India’s first human telesurgery trial
Dr. Fredric Moll, Father of Surgical Robotics, joins as Board Member and Vice Chairman to propel advancements in healthcare technology
Concept Medical enrolls first patient in ‘Magical-ISR’ IDE study in US
The MAGICAL-ISR IDE study aims to assess the safety & efficacy of this Sirolimus DCB in treating ISR, focusing on the proportion of patients avoiding TLF within 1 year post-procedure
India hospital network launched to initiate life-saving colon cancer trial
Twelve hospitals across India will be part of the network which will support the trial in India
Intravacc releases more data on its intranasal SARS-CoV-2 vaccine candidate
Additional pre-clinical data of Avacc 10®indicate reduction in upper respiratory tract viral load and cross neutralization of variants of concern
IIT Madras designed trial shows efficacy of Indomethacin drug in mild...
This research work promises a new line of treatment for mild COVID-19 infection as Indomethacin is an affordable drug and the findings of this Research have recently been published in the prestigious peer-reviewed journal Nature Scientific Reports
Bharat Biotech gets DCGI nod for Phase 3 clinical trials of...
The trials for 0.5 ml single dose of nasal vaccine will be conducted at nine locations in the country.
India’s first mRNA-based Covid-19 vaccine gets DCGI nod for Phase II...
The trial for India’s first mRNA-based vaccine from Gennova Biopharmaceuticals was found to be safe in Phase I study. Post Drugs Controller General of India approval, Phase II and Phase III trials are to commence in early September, 2021......................
Zydus completes Phase-I trials of its anti-malarial compound
Phase I healthy volunteers study demonstrated long half-life and potential for a single-dose cure for malaria. Potent antimalarial activity demonstrated in malaria challenge trial following single-dose oral administration of ZY19489.......................
Record 59 new US drugs launched in 2018, success rates fall:...
As per the study by IQVIA Institute for Human Data Science, while the likelihood that a drug entering clinical development would be a success was 11 percent, down from 14 percent in 2017, eight identified trends could increase R&D productivity by double digits during next five years.................